Reference:
1.Stratigos AJ, Dover JS, Arndt KA. Laser treatment of pigmented lesions--2000: how far have we gone?Arch Dermatol.2000;136:915–921.[PubMed]
2.AlsterTS, Lupton JR. Laser therapy for cutaneous hyperpigmentation and pigmented lesions.DermatolTher.2001;14:46–54.
3.Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation.Science.1983;220:524–
527.[PubMed]
4.Chan HH, AlamM, KonoT, Dover JS. Clinical application of lasers in Asians.DermatolSurg.2002;28:556–563.[PubMed]
5.Chan HH, Ying SY, HoWS, KonoT, King WW. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755 nm alexandrite and Q-
switched 1064 nm Nd:YAGlasers in the treatment of nevus of Ota.DermatolSurg.2000;26:919–922.[PubMed]
6.PolnikornN, TanrattanakornS, Goldberg DJ. Treatment of Hori's nevus with the Q-switched Nd:YAGlaser.DermatolSurg.2000;26:477–480.[PubMed]
7.Cho SB, Kim JS, Kim MJ. Melasmatreatment in Korean women using a 1064-nm Q-switched Nd:YAGlaser with low pulse energy.ClinExp
Dermatol.2009;34:e847–e850.[PubMed]
8.Cho SB, Park SJ, Kim MJ, Bu TS. Treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) using 1064-nm Q-switched Nd:YAGlaser with
low fluence.IntJ Dermatol.2009;48:1308–1312.[PubMed]
9.Cho SB, Park SJ, Kim JS, Kim MJ, Bu TS. Treatment of post-inflammatory hyperpigmentation using 1064-nm Q-switched Nd:YAGlaser with low fluence:
report of three cases.J EurAcadDermatolVenereol.2009;23:1206–1207.[PubMed]
10.Kim SD, Kim SW, Huh CH, SuhDH, EunHC. Changes of biophysical properties of the skin measured by non-invasive techniques after Q-switched Nd-
YAG laser therapy in patients with nevus of Ota.Skin Res Technol.2001;7:262–271.[PubMed]
11.Anderson RR. Laser-tissue interactions in dermatology. In: Arndt KA, Dover JS, OlbrichtSM, editors.Lasers in cutaneous and aesthetic
surgery.Philadelphia: Lippincott-Raven; 1997. pp. 25–32.
12.Anderson RR, Margolis RJ, WatenabeS, FlotteT, HruzaGJ, Dover JS. Selective photothermolysisof cutaneous pigmentation by Q-switched Nd:YAGlaser
pulses at 1064, 532, and 355 nm.J Invest Dermatol.1989;93:28–32.[PubMed]
13.RosenbachA, Williams CM, AlsterTS. Comparison of the Q-switched alexandrite (755 nm) and Q-switched Nd:YAG(1064 nm) lasers in the treatment of
benign melanocytic nevi.DermatolSurg.1997;23:239–244.[PubMed]
1.Gupta AK, Simpson F. Device-based therapies for onychomycosistreatment. Skin Therapy Letter. 2012; 17(9).
2.Noguchi H, Miyata K, Sugita T, HirumaM. Treatment of OnychomycosisUsing a 1064nm Nd: YAG Laser. Med MycolJ. 2013; 54(4):333-9.
3.MeestersAA, PitassiLH, Campos V, WolkerstorferA, DierickxCC. Transcutaneous laser treatment of leg veins. Lasers Med Sci. 2013 Nov 13. [Epub
ahead of print].
4.Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol.
2013 Oct;169 Suppl3:91-7. doi: 10.1111/bjd.12526.